GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Other Current Receivables

Euroapi (XPAR:EAPI) Other Current Receivables : €0 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Other Current Receivables?

Euroapi's Other Current Receivables for the quarter that ended in Dec. 2023 was €0 Mil.


Euroapi Other Current Receivables Historical Data

The historical data trend for Euroapi's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Other Current Receivables Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
16.00 18.60 - - -

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial - 35.70 - 21.60 -

Euroapi Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Euroapi Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Euroapi's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi (XPAR:EAPI) Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA offers both API Solutions and Contract Development and Manufacturing Organization CDMO. The company provides expertise in Quality, Regulatory and Supply and have dedicated commercial teams for its clients around the globe.

Euroapi (XPAR:EAPI) Headlines

No Headlines